GEMINI2 · EFC16034
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A Phase 3, randomized, double-blind efficacy and safety study comparing SAR442168 to teriflunomide (Aubagio®) in participants with relapsing forms of multiple sclerosis (GEMINI 2). EudraCT: 2020-000644-55
Sponsor: SANOFI
Phase: III
Area: Neuroimmunology